Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 16,245 | 16,350 | 16,865 | 15,567 | 15,837 |
| Gross Profit | 16,540 | 16,350 | 17,260 | 16,180 | 15,830 |
| Operating Expenses | 24,300 | 27,440 | 28,420 | 28,800 | 27,590 |
| Operating Income | -8,055 | -11,090 | -11,555 | -13,233 | -11,753 |
| Other Income | -2,305 | -1,330 | 9,915 | -177 | -7 |
| Pre-tax Income | -10,360 | -12,420 | -1,640 | -13,410 | -11,760 |
| Income Tax | 150 | 730 | N/A | 370 | N/A |
| Net Income Continuous | -10,329 | -5,640 | -1,604 | -13,257 | -19,000 |
| Net Income Discontinuous | -1,676 | -2,510 | -65,355 | -1,697 | -2,000 |
| Net Income | $-12,005 | $-8,150 | $-66,959 | $-14,954 | $-21,000 |
| EPS Basic Total Ops | -0.27 | N/A | -1.49 | -0.33 | -0.47 |
| EPS Basic Continuous Ops | -0.23 | N/A | -0.04 | -0.29 | -0.43 |
| EPS Basic Discontinuous Ops | -0.04 | N/A | -1.45 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.27 | N/A | -1.49 | -0.33 | -0.47 |
| EPS Diluted Continuous Ops | -0.23 | N/A | -0.04 | -0.29 | -0.43 |
| EPS Diluted Discontinuous Ops | -0.04 | N/A | -1.45 | -0.04 | -0.04 |
| EBITDA(a) | $-8,055 | $-11,090 | $-11,555 | $-13,233 | $-11,753 |